Parallax Health Sciences Inc Revenue Growth Rates (PRLX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Parallax Health Sciences Inc   (PRLX)
 

PRLX's Revenue Growth by Quarter and Year

Parallax Health Sciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRLX Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
4th Quarter December 0.05
3rd Quarter September 0.03
2nd Quarter June 0.00
1st Quarter March 0.05
FY 0.13

PRLXs Annual Revenue
Parallax Health Sciences Inc 's Revenue in the fiscal year 2019 $ 0.13 millions
Parallax Health Sciences Inc 's Revenue in the fiscal year 2018 $ 0.01 millions
Parallax Health Sciences Inc 's Revenue in the fiscal year 2017 $ 3.20 millions
Parallax Health Sciences Inc 's Revenue in the fiscal year 2016 $ 22.75 millions
Parallax Health Sciences Inc 's Revenue in the fiscal year 2015 $ 11.58 millions




PRLX Revenue fourth quarter 2018 Y/Y Growth Comment
Parallax Health Sciences Inc in the fourth quarter 2018 achieved Revenue of $ 0.05 millions compare to recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2018, Parallax Health Sciences Inc achieved the best Revenue growth in Medical Equipment & Supplies industry. While Parallax Health Sciences Inc ' s Revenue no change of 0% ranks overall at the positon no. 25 in the fourth quarter 2018.


PRLX Revenue ( Y/Y Growth %) 2018
 2017 2016 2015
4th Quarter December - - -94.9 % -57.14 %
3rd Quarter September - - -94.99 % 18.43 %
2nd Quarter June - - -99.56 % -
1st Quarter March - - -73.51 % -
FY   - - -89.36 % -

Financial Statements
Parallax Health Sciences Inc 's fourth quarter 2018 Revenue $ 0.05 millions PRLX's Income Statement
Parallax Health Sciences Inc 's fourth quarter 2017 Revenue $ 0.00 millions Quarterly PRLX's Income Statement


PRLX Revenue (Quarter on Quarter Growth %)

 2018
 2017 2016 2015
4th Quarter December 69.52 % - -46.43 % -47.41 %
3rd Quarter September - - 833.33 % -17.91 %
2nd Quarter June - - -98.47 % -7.97 %
1st Quarter March - - -33.33 % 7.87 %
FY (Year on Year)   - - -89.36 % -


Back to PRLX Growth rate Comparisons >> Back to PRLX Growth rate Comparisons >>


Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #3
Overall #25

Revenue Y/Y Growth Statistics
High Average Low
5036.87 % 544.38 % -99.75 %
(Dec 31 2019)   (Mar 31 2018)
Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #1
Healthcare Sector #3
Overall #25
Revenue Y/Y Growth Statistics
High Average Low
5036.87 % 544.38 % -99.75 %
(Dec 31 2019)   (Mar 31 2018)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Parallax Health Sciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
5050.51 % 381.83 % -100 %
(Mar 31 2019)  


PRLX's IV. Quarter Q/Q Revenue Comment
Parallax Health Sciences Inc achieved in the IV. Quarter 2018 below company average Revenue jump of 69.52% quarter on quarter, to $ 0.05 millions.

Although the IV. Quarter 2018 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the IV. Quarter surge, eclipses the % growth in the IV. Quarter a year ago

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Parallax Health Sciences Inc 's Revenue growth quarter on quarter, overall rank is 335.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #95
Overall #335
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #95
Overall #335
Revenue Q/Q Growth Statistics
High Average Low
5050.51 % 381.83 % -100 %
(Mar 31 2019)  


PRLX's IV. Quarter Q/Q Revenue Comment
Parallax Health Sciences Inc achieved in the IV. Quarter 2018 below company average Revenue jump of 69.52% quarter on quarter, to $ 0.05 millions.

IV. Quarter 2018 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the IV. Quarter a year ago.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Parallax Health Sciences Inc 's Revenue growth quarter on quarter, overall rank is 335.


Parallax Health Sciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2018)
Cumulative Revenue 12 Months Ending $ 0.13 $ 0.08 $ 0.05 $ 0.06 $ 0.01
Y / Y Revenue Growth (TTM) 995.49 % -50.37 % -87.77 % -87.47 % -99.51 %
Year on Year Revenue Growth Overall Ranking # 44 # 2669 # 3597 # 3437 # 3583
Seqeuential Revenue Change (TTM) 63.33 % 46.16 % -6.86 % 392.71 % -92.6 %
Seq. Revenue Growth (TTM) Overall Ranking # 4044 # 3933 # 3400 # 8 # 191


Cumulative Revenue growth Comment
With 995.49% annual Revenue growth, Parallax Health Sciences Inc would report a record annual Revenue surge if the fiscal year would end on Dec 31 2019.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 44, from total ranking in previous quarter at 2669.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 5
Overall # 44

Revenue TTM Y/Y Growth Statistics
High Average Low
995.49 %
 14.22 %
-99.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 533
S&P 500 # 4044
Cumulative Revenue growth Comment
With 995.49% annual Revenue growth, Parallax Health Sciences Inc would report a record annual Revenue surge if the fiscal year would end on Dec 31 2019.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 44, from total ranking in previous quarter at 2669.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 5
Overall # 44

Revenue TTM Y/Y Growth Statistics
High Average Low
995.49 %
14.22 %
-99.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 533
S&P 500 # 4044




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRLX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2019
Palisade Bio Inc 0.00%$ 0.000 millions
Navidea Biopharmaceuticals Inc -0.02%$ -0.018 millions
Mannkind Corporation-0.24%$ -0.237 millions
Alpha Pro Tech Ltd -0.46%$ -0.456 millions
Amgen Inc -0.53%$ -0.530 millions
American Bio Medica Corporation-0.57%$ -0.566 millions
Wearable Health Solutions, Inc.-0.58%$ -0.582 millions
Societal Cdmo Inc -0.79%$ -0.787 millions
Ufp Technologies Inc -0.86%$ -0.862 millions
Heska Corporation-0.87%$ -0.872 millions
Orasure Technologies Inc-1.15%$ -1.150 millions
Atrion Corporation-1.32%$ -1.317 millions
Titan Pharmaceuticals Inc -1.54%$ -1.537 millions
Elanco Animal Health Incorporated-1.54%$ -1.539 millions
Global Cord Blood Corp-1.55%$ -1.548 millions
Dynatronics Corporation-1.57%$ -1.574 millions
Phibro Animal Health Corporation-1.93%$ -1.930 millions
Magellan Health inc -2.28%$ -2.276 millions
Aquestive Therapeutics Inc -2.41%$ -2.407 millions
Endo International Plc-2.75%$ -2.745 millions
Scorpius Holdings inc -2.87%$ -2.868 millions
Beone Medicines Ltd -3.03%$ -3.031 millions
Intersect Ent Inc -3.14%$ -3.139 millions
Livanova Plc-3.16%$ -3.163 millions
Ironwood Pharmaceuticals inc -3.36%$ -3.360 millions
Accuray Incorporated-3.41%$ -3.413 millions
Arbutus Biopharma Corp-3.58%$ -3.576 millions
Encision Inc -3.71%$ -3.709 millions
Invacare Holdings Corporation-4.77%$ -4.769 millions
Community Health Systems Inc -4.84%$ -4.836 millions


About Parallax Health Sciences Inc Revenue Growth Rates (PRLX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.